COVID-19 Vaccine Researchers Mindful of Immune Enhancement
COVID-19 Vaccine Researchers Mindful of Immune Enhancement
There is no evidence that any of the coronavirus vaccines in development worsen a coronavirus infection rather than confer immunity to it, but the phenomenon is something scientists are closely monitoring.
COVID-19 Vaccine Researchers Mindful of Immune Enhancement
COVID-19 Vaccine Researchers Mindful of Immune Enhancement

There is no evidence that any of the coronavirus vaccines in development worsen a coronavirus infection rather than confer immunity to it, but the phenomenon is something scientists are closely monitoring.

There is no evidence that any of the coronavirus vaccines in development worsen a coronavirus infection rather than confer immunity to it, but the phenomenon is something scientists are closely monitoring.

antibodies
Biogen Uses its Own Superspreader Event to Aid COVID-19 Research
Biogen Uses its Own Superspreader Event to Aid COVID-19 Research
Claire Jarvis | May 19, 2020
A blood biobank allows scientists to study the immune responses to the coronavirus among infected Biogen employees and their contacts.
special report
Why the Accuracy of SARS-CoV-2 Antibody Tests Varies So Much
Why the Accuracy of SARS-CoV-2 Antibody Tests Varies So Much
Diana Kwon | May 5, 2020
The FDA cracks down on test makers as independent evaluations of their products’ performance show a need for improvement.
special report
How (Not) to Do an Antibody Survey for SARS-CoV-2
How (Not) to Do an Antibody Survey for SARS-CoV-2
Catherine Offord | Apr 28, 2020
Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.
Opinion: Public Health Trumps Privacy in a Pandemic
Opinion: Public Health Trumps Privacy in a Pandemic
John D. Loike, Ruth L. Fischbach | Apr 16, 2020
If governments were to use SARS-CoV-2 antibody tests to manage who can re-enter the workplace, society must accept a sacrifice of privacy.
FDA to Allow for Plasma Therapy for COVID-19 Patients
FDA to Allow for Plasma Therapy for COVID-19 Patients
Lisa Winter | Mar 26, 2020
Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  
Monkeys Develop Protective Antibodies to SARS-CoV-2
Monkeys Develop Protective Antibodies to SARS-CoV-2
Katarina Zimmer | Mar 17, 2020
A small study of macaques finds they don’t develop a coronavirus infection the second time they are exposed, supporting the idea of using plasma from recovered patients as a treatment for COVID-19.
How SARS-CoV-2 Tests Work and What’s Next in COVID-19 Diagnostics
How SARS-CoV-2 Tests Work and What’s Next in COVID-19 Diagnostics
Bianca Nogrady | Mar 3, 2020
Current methods to detect infections of the novel coronavirus rely on identifying particular genetic sequences, but new assays are being developed to meet the growing demand for rapid answers.
Philip Leder, Who Deciphered Amino Acid Sequences, Dies
Philip Leder, Who Deciphered Amino Acid Sequences, Dies
Ashley Yeager | Feb 12, 2020
The Harvard Medical School researcher’s work on the genetic basis of protein coding and production led him to make groundbreaking discoveries in immunology, molecular biology, and cancer genetics.
Faulty Antibodies Undermine Widespread Research
Faulty Antibodies Undermine Widespread Research
Ruth Williams | Jan 30, 2020
Two papers reveal that many commonly used research antibodies don’t bind as believed, highlighting the need to validate these reagents before use.